Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association Between Initial Oral Therapy and Outcomes in Systemic Sclerosis-Related Pulmonary Arterial Hypertension

Published:2016-02-24 Issue:3 Volume:68 Page:740-748
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Lammi Matthew R.¹,Mathai Stephen C.²,Saketkoo Lesley Ann³,Domsic Robyn T.⁴,Bojanowski Christine¹,Furst Daniel E.⁵,Steen Virginia D.⁶,

Affiliation:

1. Louisiana State University Health Sciences Center; New Orleans

2. Johns Hopkins University; Baltimore Maryland

3. Tulane University School of Medicine; New Orleans Louisiana

4. University of Pittsburgh; Pittsburgh Pennsylvania

5. University of California; Los Angeles

6. Georgetown University School of Medicine; Washington DC

Funder

NIH

Pulmonary Hypertension Association

Scleroderma Foundation

Sibley Hospital Foundation

Actelion

Gilead

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference38 articles.

1. Systemic sclerosis-associated pulmonary arterial hypertension [review];Chaisson;Chest,2013

2. Changes in causes of death in systemic sclerosis, 1972-2002;Steen;Ann Rheum Dis,2007

3. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension;Fisher;Arthritis Rheum,2006

4. Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials;Avouac;Ann Rheum Dis,2008

5. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension;Galie;Eur Heart J,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk stratification and treatment goals in pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

2. Sildenafil Versus Placebo for Early Pulmonary Vascular Disease in Scleroderma (SEPVADIS): protocol for a randomized controlled trial;BMC Pulmonary Medicine;2024-04-30

3. Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis;Rheumatology;2023-07-18

4. The S100A7 nuclear interactors in autoimmune diseases: a coevolutionary study in mammals;Immunogenetics;2022-02-16

5. 2020 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension;Russian Journal of Cardiology;2021-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3